Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men

Atherosclerosis

Volumn 121, Issue 1, 1996, Pages 35-43

  Zgliczynski, Stefan ^a   Ossowski, Marcin ^a   Slowinska Srzednicka, Jadwiga ^a   Brzezinska, Agnieszka ^a   Zgliczynski, Wojciech ^a   Soszynski, Piotr ^a   Chotkowska, Ewa ^b   Srzednicki, Marek ^b   Sadowski, Zygmunt ^b  

^a BIELANSKI HOSPITAL   (Poland)

^b INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Hypopgonadism; Lipids; Lipoproteins; Testosterone replacement therapy

Indexed keywords

GONADOTROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; LIPID; LIPOPROTEIN; TESTOSTERON PROLONGATUM; TESTOSTERONE; TESTOSTERONE ENANTATE; THYROXINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HORMONE SUBSTITUTION; HUMAN; HYPOANDROGENISM; HYPOGONADISM; HYPOPITUITARISM; INTRAMUSCULAR DRUG ADMINISTRATION; LIPID METABOLISM; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL;

EID: 0029669976     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05673-4     Document Type: Article

References (45)

1. Ganger K, Vyas S, Whitehead MI, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991;338:839.
2. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in post-menopausal women. N Engl J Med 1993;328:1069.
3. Slowinska-Srzednicka J, Zgliczynski S, Chotkowska E, Srzednicki M, Stopinska-Gluszak U, Jeske W, Brzezinska A, Zgliczynski W, Sadowski Z. Effects of transdermal 17β-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic post-menopausal women. J Int Med 1993;234:447.
4. Lobo RA. Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J Clin Endocrinol Metab 1991;73:925.
5. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users. Arch Intern Med 1993;153:73.
6. Wolf PH, Madans JH, Finucane FF, Higgins M, Kleinman JC. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. Am J Obstet Gynecol 1991;164:489.
7. Godsland BA, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987;114:1467.
8. Morrison JA, Laskarzewski PM, Rauh JL, Brookman R, Mellies M, Frazer M, Khoury P, deGroot I, Kely K, Glueck CJ. Lipids, lipoproteins and sexual maturation during adolescence. The Princeton Maturation Study. Metabolism 1979;28:641.
9. Laskarzewski PM, Morrison JA, Gutai J, Orchard T, Khoury PR, Glueck CJ. High and low density lipoprotein cholesterols in adolescent boys. Relationships with endogenous testosterone, estradiol and quetelet index. Metabolism 1983;32:262.
10. Furman RH, Howard RP, Norcia LN, Keaty EC. The influence of androgens, estrogens and related steroids on serum lipids and lipoproteins. Am J Med 1958;24:80.
11. Olsson AG, Oro L, Rossner S. The effect of the anabolic steroid oxandrolone on lipoproteins. Atherosclerosis 1974;19:336.
12. Webb OL, Laskarzewski PM, Glueck CJ. Severe depression of high density lipoprotein cholesterol levels in weight lifters and body builders by self administered exogenous testosterone and anabolic-androgenic steroids. Metabolism 1984;33:971.
13. Haffner SM, Kushwaha RS, Foster DM, Applebaum-Bowden D, Hazzard WR. Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism 1983;32:413.
14. Gutai JP, LaPorte RE, Kuller L, Dai W, Falvo-Gerard L, Caggiula A. Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. Am J Cardiol 1981;48:897.
15. Dai WS, Gutai JP, Kuller LH, LaPorte RE, Falvo-Gerard L, Caggiula A. Relation between plasma high-density lipoprotein cholesterol and sex-hormone concentrations in men. Am J Cardiol 1984;53:1259.
16. Khaw KT, Barrett-Connor E. Endogenous sex hormones, high density lipoprotein cholesterol and other lipoprotein fractions in men. Arteriosclerosis Thromb 1991;14:489.
17. Freedman DS, O'Brien TR, Flanders WD, DeStefano F, Barboriak JJ. Relation of serum testosterone levels to high density lipoprotein cholesterol and other characteristics in men. Arteriosclerosis Thromb 1991;11:307.
18. Breier C, Muhlberger V, Drexel H, Herold M, Lisch HJ, Knapp E, Braunsteiner H. Essential role of post-heparin lipoprotein lipase activity and of plasma testosterone in coronary artery disease. The Lancet 1985;1:1242.
19. Slowinska-Srzednicka J, Zgliczynski S, Ciswicka-Sznajderman M, Srzednicki M, Soszynski P, Biernacka M, Woroszylska M, Ruzyllo W, Sadowski Z. Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis 1989;79:197.
20. Lichtenstein MJ, Yarnell JWG, Elwood PC. Sex hormones, insulin, lipids and prevalent ischemic heart disease. Am J Epidemiol 1987;126:647.
21. Heller RF, Jacobs HS, Vermeulen A, Despylere JP. Androgens, oestrogens and coronary heart disease. Br Med J 1981;282:438.
22. Phillips GB. Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. Metabolism 1993;42:116.
23. Oppenheim DS, Greenspan SL, Zervas NT, Schoenefeld DA, Klibanski A. Elevated serum lipids in hypogonadal men with and without hyperprolactinemia. Ann Int Med 1989;111:288.
24. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992;75:1092.
25. Morley JE, Perry HM, Kaiser FE, Kraenzle D, Jensen J, Houston K, Mattammal M, Perry HM Jr. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 1993;41:149.
26. Gidez LJ, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206.
27. Greenspan SL, Oppenheim DS, Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Int Med 1989;110:526.
28. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Serge GV, Crowley WF. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989;69:776.
29. Thompson PD, Cullinane EM, Sady SP, Chenevert C, Saritelli AL, Sady MA, Herbert PW. Contrasting effects of testosterone and stanazolol on serum lipoprotein levels. J Am Med Assoc 1989;261:1165.
30. Miller NE. Associations of high density lipoprotein subclasses with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987;113:589.
31. Bagatell CJ, Knopp RH, Rivier JE, Bremner WJ. Physiological levels of estradiol stimulate plasma high density Iipoprotein2 cholesterol levels in normal men. J Clin Endocrinol Metab 1994;78:855.
32. Zmuda JM, Fahrenbach MC, Younkin BT, Bausserman LL, Terry RB, Catlin DH, Thompson PD. The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity. Metabolism 1993;42:446.
33. Handelsman DJ, Conway M, Boylan LM. Suppresion of human spermatogenesis by testosterone implants. J Clin Endocrinol Metab 1992;75:1326.
34. Jones DB, Higgins B, Billet JS, Price WH, Edwards CRW, Beasthall GH, Shepherd J, Sweeting VM, Horn DB, Wenham PR. The effects of testosterone replacement on plasma lipids and apolipoproteins. Eur J Clin Invest 1989;19:438.
35. Liu L, Merriam GR, Sherins RJ. Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1987;64:651.
36. Marin P, Holmäng S, Jansson L et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes 1992;16:991.
37. Schaefer EJ, Foster DM, Zech LA, Lindgren BT, Brewer HB Jr, Levy RI. The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab 1983;57:262.
38. Kesaniemi YA, Witztum JL, Steinbrecher U. Receptor-mediated catabolism of low density lipoprotein in man: quantitation using glycosylated low density lipoproteins. J Clin Invest 1983;71:950.
39. Crook D, Seed M. Endocrine control of plasma lipoprotein metabolism: effects of gonadal steroids. Bailliere's Clin Endocrinol Metab 1990;4:851.
40. Eriksson M, Berglund L, Rudling M, Hanriksson P, Angelin B. Effects of estrogen on low density lipoprotein metabolism in males. J Clin Invest 1989;84:802.
41. Angelin B, Rudling M, Olivecrona H, Ericsson S. Effects of growth hormone on low-density lipoprotein metabolism. Acta Paediatr 1992;Suppl 383:67.
42. Chait A, Bierman EL, Alberts JL. Low-density lipoprotein receptor activity in cultured human skin fibroblasts. J Clin Invest 1979;64:1309.
43. Tikkanen MJ, Nikkila EA. Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am Heart J 1987;113:562.
44. Goldberg IJ, Le N-A, Peterniti JR, Ginberg HN, Lindgren FT. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest 1982;70:1184.
45. Sorva R, Kuusi T, Taskinen MR, Perheentupa J, Nikkila EA. Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males. Atherosclerosis 1988;69:191.